A patient with a diagnosis of nodal marginal zone B-cell lymphoma and a t(2;14)(p24;q32) involving MYCN and IGH

被引:4
作者
Brown, Angela [1 ]
Sciascia-Visani, Isabella [1 ]
Farrell, Dianna [1 ]
Smith, Meg [1 ]
Felix, Clive [1 ]
Mutharajah, Vanaja [2 ]
Ruell, Jackie [4 ]
Taylor, Graeme [3 ]
机构
[1] Wellington Hosp, Genet Serv, Riddiford St, Wellington 6021, New Zealand
[2] Wellington Hosp, Dept Pathol, Riddiford St, Wellington 6021, New Zealand
[3] Nelson Hosp, Dept Pathol, 115 Kawai St, Nelson South 7010, Nelson, New Zealand
[4] Wellington Hosp, Dept Haematol, Riddiford St, Wellington 6021, New Zealand
关键词
Marginal zone B-cell lymphoma; MYCN; Translocation; OCCUR;
D O I
10.1186/s13039-019-0419-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundNodal marginal zone B-cell lymphoma is a rare entity in which the cytogenetic findings are not well defined. The t(2;14)(p24;q32) has previously been reported in three patients with blastic mantle cell lymphoma and one patient with follicular lymphoma. This rearrangement has not been reported previously in a patient with a diagnosis of nodal marginal zone B-cell lymphoma.Case presentationWe present a male patient who presented with lymphadenopathy. On the basis of his clinicoradiologic presentation, morphological appearances, immunophenotype and molecular findings he was determined to have a diagnosis of nodal marginal zone B-cell lymphoma. Cytogenetic analysis demonstrated a t(2;14)(p24;q32). Further FISH testing showed this rearrangement to involve the MYCN and IGH genes.ConclusionsWe present the first patient with a diagnosis of nodal marginal zone B-cell lymphoma with a t(2;14)(p24;q32). This rearrangement has been described in three other patients who have had a diagnosis of lymphoma. Our findings suggest this rearrangement is not specific to mantle cell lymphoma or follicular lymphoma. The number of cases described are still too low to draw firm conclusions regarding the nature of this rearrangement. In order to refine the clinical and prognostic picture of this finding, publication of further cases is required.
引用
收藏
页数:5
相关论文
共 15 条
  • [1] [Anonymous], 2017, ONL MEN INH MAN OMIM
  • [2] [Anonymous], 2017, WHO CLASSIFICATION T
  • [3] Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities
    Braggio, Esteban
    Dogan, Ahmet
    Keats, Jonathan J.
    Chng, Wee J.
    Huang, Gaofeng
    Matthews, Julie M.
    Maurer, Matthew J.
    Law, Mark E.
    Bosler, David S.
    Barrett, Michael
    Lossos, Izidore S.
    Witzig, Thomas E.
    Fonseca, Rafael
    [J]. MODERN PATHOLOGY, 2012, 25 (05) : 651 - 660
  • [4] Brynes RK, 1996, MODERN PATHOL, V9, P995
  • [5] Cogliatti S, 2016, SWISS MED WKLY, V146, p1S
  • [6] Heim S., 2015, Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, V4th
  • [7] Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013
    Huret, Jean-Loup
    Ahmad, Mohammad
    Arsaban, Melanie
    Bernheim, Alain
    Cigna, Jeremy
    Desangles, Francois
    Guignard, Jean-Christophe
    Jacquemot-Perbal, Marie-Christine
    Labarussias, Maureen
    Leberre, Vanessa
    Malo, Anne
    Morel-Pair, Catherine
    Mossafa, Hossein
    Potier, Jean-Claude
    Texier, Guillaume
    Viguie, Franck
    Wan-Senon, Sylvie Yau Chun
    Zasadzinski, Alain
    Dessen, Philippe
    [J]. NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D920 - D924
  • [8] McGowan-Jordan J, 2016, ISCN 2016 INT SYSTEM
  • [9] Nodal and splenic marginal zone B cell lymphomas
    Mollejo, M
    Camacho, FI
    Algara, P
    Ruiz-Ballesteros, E
    García, JF
    Piris, MA
    [J]. HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 108 - 118
  • [10] MDM2 as a critical effector of the MYCN oncogene in tumorigenesis
    Slack, A
    Shohet, JM
    [J]. CELL CYCLE, 2005, 4 (07) : 857 - 860